Mary T Szela Insider Trading $CHRS Coherus BioSciences, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mary T Szela.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mary T Szela. Mary T Szela is Senior Vice President in ABBOTT LABORATORIES ($ABT) and Chief Executive Officer in QLT INC/BC ($QLTI) and Director in ALIMERA SCIENCES INC ($ALIM) and Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and Director in Kura Oncology, Inc. ($KURA) and Director in Receptos, Inc. ($RCPT) and Director in Coherus BioSciences, Inc. ($CHRS) and Director in Prometheus Biosciences, Inc. ($RXDX).
Mary T Szela in Coherus BioSciences, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mary T Szela: Director
Holdings: 14,997 shares
Current Value: $399,670
Latest Transaction: Jan 13 2021
$CHRS Market Capitalization: $1.03B
$CHRS Previous Close: $26.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mary T Szela in Coherus BioSciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, AEGR, ALIM, CHRS, KURA, NVLN, RXDX, RCPT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 13 2021 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
| Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | M | 12.37 | 20,000 | 247,400 | 0 | |
| Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | M | 10.05 | 20,000 | 201,000 | 0 | |
| Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | M | 2.50 | 14,997 | 37,500 | 0 | |
| Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Sell | S | 17.58 | 54,997 | 966,759 | 0 | 55 K to 0 (-100.00 %) |
| Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Buy | M | 12.37 | 20,000 | 247,400 | 54,997 | 35 K to 55 K (+57.15 %) |
| Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Buy | M | 10.05 | 20,000 | 201,000 | 34,997 | 15 K to 35 K (+133.36 %) |
| Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Buy | M | 2.50 | 14,997 | 37,500 | 14,997 | 0 to 15 K |
| Jan 14 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 17.73 | 20,000 | 354,600 | 20,000 | |
| Jan 30 2019 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 12.37 | 20,000 | 247,400 | 20,000 | |
| May 19 2017 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 23.80 | 20,000 | 476,000 | 20,000 | |
| May 26 2016 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 18.28 | 10,000 | 182,800 | 10,000 | |
| Apr 03 2015 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 29.00 | 20,000 | 580,000 | 20,000 |
Page: 1